Evaluating Oral Treatment Options for the Initial Management of Osteoarthritis
Thank you Prof Philip Conaghan, Dr Patricia Franklin, Dr John Grady-Benson, Jean-Yves Reginster MD, PhD and Prof Ola Rolfson MD for delivering such an insightful session today detailing how outcomes measurement can
BioMedEng Association on Twitter: "Our fourth plenary speaker for #BioMedEng21 is Prof Conaghan, Director of the Leeds Institute of Rheumatic and Musculoskeletal Medicine & Deputy Director @LeedsBRC More about Philip: https://t.co/NnhkJWy6cl @insigneo @
Little improvement seen in OA therapeutics
Young adult books roundup: contender for 'best of 2019' lists
What's up in the osteoarthritis drug pipeline | MDedge Rheumatology
Phil Conaghan shares animal handling tips with livestock transporters | Queensland Country Life | Queensland
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating ...
Dunedin Hospital | Spire Healthcare
MRI Poised to Boost Early Osteoarthritis Detection | MDedge Rheumatology
Philip G Conaghan's research works | University of Leeds, Leeds and other places
Manchester United Medical Conference - Registration
Professor Phillip Conaghan talks AposTherapy knee pain treatment - YouTube
Leadership Team - Leeds Biomedical Research Centre
Dunedin Hospital | Spire Healthcare
Philip G Conaghan's research works | University of Leeds, Leeds and other places
Cathepsin K inhibitor exhibits bone protecting effects in osteoarthritis | MDedge Rheumatology
Focus on CSyP: John Conaghan - City Security Magazine
Mr Philip Conaghan - Colorectal Surgeon | Endoscopy & Hernia Repair Surgery | Reading, Berkshire | Spire Dunedin Hospital
Fast Facts: Osteoarthritis and Gout : Philip Conaghan : 9781903734810
Methotrexate significantly reduced knee OA pain | MDedge Rheumatology
Philip Conaghan, WCO21: Tanezumab in the Treatment of Patients with Moderate-to-severe Osteoarthritis - touchIMMUNOLOGY
Philip Conaghan, MBBS, PhD: Efficacy of Tanezumab in Patients With Osteoarthritis
Cardiff University School of Medicine on Twitter: "Prof Philip Conaghan, Professor of Musculoskeletal Medicine, University of Leeds enlightening the audience. Who knew there were over 200 types of arthritis? https://t.co/gQXbUfyUMZ https://t.co ...
Professor Philip Conaghan - BioMedEng21
Advancing Osteoarthritis Care: Current and Emerging Evidence for Improving Long-term Outcomes
EDITORIAL BOARD MEMBER | British Journal of Sports Medicine
Arthritis remedies: Experts reveal which treatments really work | Daily Mail Online
